Table 1.
Antibacterial activity of structurally related compounds and parent terpenes against Gram-positive and Gramnegative reference strains.
Compound | Minimum Inhibitory Concentrations MIC (µg/mL) | |||||
---|---|---|---|---|---|---|
Gram-Positive Bacteria | Gram-Negative Bacteria | |||||
Staphylococcus aureus ATCC 43300 | Enterococcus faecalis ATCC 51299 | Enterococcus faecium ATCC 35667 | Escherichia coli ATCC 25922 | Klebsiella pneumoniae ATCC 700603 | Acinetobacter baumannii ATCC 19606 | |
Geranyl acetone (1) | 48 | 36 | 28 | 26 | 18 | 18 |
6 | 26 | 18 | 16 | 14 | 14 | 12 |
7 | 26 | 16 | 18 | 16 | 16 | 14 |
8 | 38 | 26 | 28 | 18 | 18 | 22 |
9 | 28 | 18 | 14 | 28 | 18 | 16 |
10 | 46 | 26 | 18 | 32 | 18 | 16 |
11 | 26 | 22 | 18 | 28 | 28 | 14 |
Nerolidol (2) | 48 | 38 | 32 | 46 | 16 | 26 |
12 | 48 | 46 | 42 | 40 | 28 | 26 |
13 | 46 | 42 | 38 | 40 | 20 | 22 |
14 | 48 | 38 | 36 | 38 | 18 | 28 |
15 | 46 | 48 | 38 | 28 | 16 | 16 |
16 | 48 | 38 | 36 | 32 | 24 | 22 |
17 | 48 | 38 | 38 | 46 | 18 | 16 |
Farnesal (3) | 24 | 22 | 36 | 46 | 44 | 36 |
18 | 18 | 22 | 28 | 52 | 46 | 46 |
19 | 28 | 34 | 38 | 44 | 36 | 42 |
20 | 22 | 20 | 32 | 48 | 38 | 38 |
21 | 32 | 38 | 42 | 54 | 48 | 52 |
22 | 26 | 24 | 46 | 44 | 36 | 36 |
23 | 28 | 26 | 36 | 46 | 34 | 36 |
Farnesol (4) | 26 | 18 | 16 | 28 | 16 | 18 |
24 | 22 | 18 | 32 | 52 | 44 | 40 |
25 | 28 | 32 | 34 | 50 | 48 | 44 |
26 | 32 | 30 | 36 | 48 | 42 | 38 |
27 | 28 | 26 | 18 | 36 | 18 | 34 |
28 | 26 | 18 | 16 | 28 | 16 | 18 |
29 | 28 | 22 | 18 | 38 | 36 | 32 |
Farnesyl acetate (5) | 28 | 20 | 20 | 28 | 22 | 22 |
30 | 30 | 24 | 18 | 30 | 24 | 24 |
31 | 24 | 20 | 20 | 26 | 22 | 18 |
32 | 28 | 22 | 20 | 28 | 18 | 22 |
33 | 26 | 18 | 16 | 26 | 18 | 22 |
34 | 32 | 20 | 18 | 18 | 20 | 18 |
35 | 34 | 16 | 14 | 16 | 18 | 12 |
Ciprofloxacin | 8 | 2 | 8 | 4 | 2 | 4 |
Gentamicin | 16 | >64 * | 32 | 4 | 32 | 32 |
* The maximum examined concentration was 64 µg/mL.